Journal of the American Society of Nephrology, Vol 6, 1250-1255, Copyright © 1995 by American Society of Nephrology

REGULAR ARTICLES

Thromboelastography for the prediction of bleeding after transplant renal biopsy

CL Davis and WL Chandler
Department of Medicine, University of Washington Medical Center, Seattle, USA.

The ability of prebiopsy coagulation assays to predict mild postbiopsy bleeding was evaluated in renal transplant patients undergoing renal allograft biopsy (N = 120). The coagulation assays studied included the bleeding time, prothrombin time, partial thromboplastin time, platelet count, and thromboelastograph (TEG). Coagulation results were defined as abnormal if they fell outside the established normal reference range. Bleeding was defined as a drop in the hematocrit equal to or more than 4 points 6 h after the procedure or ultrasound evidence of a new perirenal hematoma. Overall, 21% of patients showed evidence of mild bleeding. Of those who bled, 78% had normal results on all coagulation tests, indicating that most mild bleeding was not associated with coagulation abnormalities. Of the assays tested, only abnormal TEG:angle (P < 0.01) and TEG:k (P < 0.04) values were associated with an increased risk of bleeding. Bleeding times were not predictive of an increased risk of postbiopsy bleeding; five patients had abnormal bleeding times ranging from 10 to 20 min of whom only one bled. All prothrombin time, partial thromboplastin time, and platelet count abnormalities were mild (e.g., no prothrombin times longer than 15 s, no platelet counts below 129,000/microL); none of these assays predicted postbiopsy bleeding. Other clinical characteristics, including patient age, sex, serum creatinine, blood pressure (if less than 160/90 mm Hg), number of biopsy passes, or renal pathology, did not appear to influence bleeding after biopsy. It was concluded that most bleeding after transplant renal biopsy was not associated with coagulation abnormalities and that the TEG was the best assay for detecting mild coagulation abnormalities associated with an increased risk of bleeding.

This article has been cited by other articles:

				Y. Kwok, K. F. J. Ng, C. C. F. Li, C. C. K. Lam, and R. Y. K. Man A Prospective, Randomized, Double-Blind, Placebo-Controlled Study of the Platelet and Global Hemostatic Effects of Ganoderma Lucidum (Ling-Zhi) in Healthy Volunteers Anesth. Analg., August 1, 2005; 101(2): 423 - 426. [Abstract] [Full Text] [PDF]

				R.J. McDonagh, J.G. Ray, R.F. Burrows, E.A. Burrows, and M.J. Vermeulen Platelet count may predict abnormal bleeding time among pregnant women with hypertension and preeclampsia : [La numeration plaquettaire peut permettre de predire le temps de saignement chez des parturientes atteintes d'hypertension et de pre-eclampsie] Can J Anesth, June 1, 2001; 48(6): 563 - 569. [Abstract] [Full Text]

				N. L. Law, K. F. J. Ng, M. G. Irwin, and J. S. F. Man Comparison of coagulation and blood loss during anaesthesia with inhaled isoflurane or intravenous propofol Br. J. Anaesth., January 1, 2001; 86(1): 94 - 98. [Abstract] [Full Text] [PDF]

				T N Chau, Y W Chan, D Patch, S Tokunaga, L Greenslade, and A K Burroughs Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding Gut, August 1, 1998; 43(2): 267 - 271. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673